ETERNYGEN
Eternygen is a Berlin based start up founded in June 2012 focusing on research and development of innovative drugs using a network of renowned scientists and contract research organizations. The main focus of Eternygen’s development and core competences of its founders are research and development of new drugs for dietary-related metabolic diseases with dramatically increasing prevalences in the last decades. Eternygen’s research addresses the sodium coupled citrate transporter NaCT which is a key regulator of lipid metabolism involved in the pathogenesis of fatty liver, diabetes and obesity. Company’s emphasis is the development of a safe and effective drug for treatment of these widespread diseases via targeted adjustment of underlying metabolic failure.
ETERNYGEN
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2012-06-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.eternygen.de
Total Employee:
1+
Status:
Active
Contact:
49 30 1207 6983 0
Total Funding:
8 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
Amadeite
Amadeite offers research and development of active ingredients, including algae bio-resources to find natural alternatives.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Evotec
Evotec investment in Series A - Eternygen
Epidarex Capital
Epidarex Capital investment in Series A - Eternygen
VC Fonds Technologie Berlin
VC Fonds Technologie Berlin investment in Series A - Eternygen
Official Site Inspections
http://www.eternygen.de
- Host name: wp679.webpack.hosteurope.de
- IP address: 5.175.14.201
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
